Development Candidates
AIV001
Prolonged-Release Formulation For Intradermal Treatment
AIV007
Gel Formulation Designed for Less Frequent Injection Regimen
JEL® Technology
Proprietary technology that is customizable to optimize drug release and therapeutic effect